Literature DB >> 22027206

Tumefactive multiple sclerosis: an uncommon diagnostic challenge.

Martha A Kaeser1, Frank Scali, Frank P Lanzisera, Glenn A Bub, Norman W Kettner.   

Abstract

OBJECTIVE: This case report describes a rare presentation of multiple sclerosis (MS) that was initially diagnosed as a peripheral nerve lesion in the emergency department. CLINICAL FEATURES: A 30-year-old woman presented to a chiropractic teaching clinic with a complaint of a sudden right foot drop. Magnetic resonance imaging of the brain revealed a large mass in the left parietal lobe with additional white matter lesions. The mass and smaller lesions were consistent with a rare presentation of demyelinating disease, tumefactive MS. INTERVENTION AND OUTCOME: The patient was referred to a neurologist for further evaluation and treatment. Her short-term clinical course was punctuated by recurrent myospasms and neurologic deficits.
CONCLUSION: Tumefactive MS may mimic the clinical and magnetic resonance imaging characteristics of glioma or a cerebral abscess. The clinical presentation, pathophysiology, differential diagnosis, role of diagnostic imaging, and treatment options of MS are described. This case report illustrates that the timely diagnosis and optimal treatment of MS require recognition of its varied, sometimes atypical, and often nonspecific clinical and imaging manifestations.
Copyright © 2011 National University of Health Sciences. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2010        PMID: 22027206      PMCID: PMC3110404          DOI: 10.1016/j.jcm.2010.08.002

Source DB:  PubMed          Journal:  J Chiropr Med        ISSN: 1556-3707


  29 in total

Review 1.  Natural history of multiple sclerosis.

Authors:  Orhun H Kantarci; Brian G Weinshenker
Journal:  Neurol Clin       Date:  2005-02       Impact factor: 3.806

Review 2.  Neuropathobiology of multiple sclerosis.

Authors:  John W Peterson; Bruce D Trapp
Journal:  Neurol Clin       Date:  2005-02       Impact factor: 3.806

Review 3.  Gender issues.

Authors:  Patricia K Coyle
Journal:  Neurol Clin       Date:  2005-02       Impact factor: 3.806

Review 4.  The gray aspects of white matter disease in multiple sclerosis.

Authors:  Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

Review 5.  The clinical epidemiology of multiple sclerosis.

Authors:  Christian Confavreux; Sandra Vukusic
Journal:  Neuroimaging Clin N Am       Date:  2008-11       Impact factor: 2.264

6.  Promising treatments of tomorrow for multiple sclerosis.

Authors:  Daniel M Harrison; Peter A Calabresi
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

Review 7.  Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Brain       Date:  2010-07       Impact factor: 13.501

8.  Resistance training improves muscle strength and functional capacity in multiple sclerosis.

Authors:  U Dalgas; E Stenager; J Jakobsen; T Petersen; H J Hansen; C Knudsen; K Overgaard; T Ingemann-Hansen
Journal:  Neurology       Date:  2009-11-03       Impact factor: 9.910

Review 9.  Vitamin D as an immune modulator in multiple sclerosis, a review.

Authors:  Joost Smolders; Jan Damoiseaux; Paul Menheere; Raymond Hupperts
Journal:  J Neuroimmunol       Date:  2008-01-04       Impact factor: 3.478

10.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

View more
  9 in total

1.  Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.

Authors:  Rocco Totaro; C Di Carmine; A Splendiani; S Torlone; L Patriarca; C Carrocci; S Sciamanna; C Marini; A Carolei
Journal:  Neurol Sci       Date:  2016-04-15       Impact factor: 3.307

2.  Population-based incidence and clinico-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States.

Authors:  Mahboubeh Fereidan-Esfahani; Paul A Decker; Jeanette E Eckel Passow; Claudia F Lucchinetti; Eoin Patrick Flanagan; William Oliver Tobin
Journal:  Eur J Neurol       Date:  2021-12-09       Impact factor: 6.089

3.  Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System.

Authors: 
Journal:  Chin Med J (Engl)       Date:  2017-08-05       Impact factor: 2.628

4.  Tumefactive multiple sclerosis masquerade as a central nervous system tumor: a case report.

Authors:  Alaa Nabil Turkistani; Foziah Jabbar Alshamrani; Ghadah Faisal Shareefi; Abdulla Alsulaiman
Journal:  Electron Physician       Date:  2018-08-25

5.  Tumefactive multiple sclerosis versus high-grade glioma: A diagnostic dilemma.

Authors:  Heath David French
Journal:  Surg Neurol Int       Date:  2021-05-03

6.  Tumefactive multiple sclerosis versus high grade glioma: A diagnostic dilemma.

Authors:  Heath French; Ariadna Fontes-Villalba; Monish Maharaj; Catherine Soo Yee Naidoo; Kartik Bhatia; Amanda Paterson; Raymond Cook; John Parratt
Journal:  Surg Neurol Int       Date:  2022-04-15

7.  When Evaluating a New Thyroid Mass and a Ring-Enhancing Brain Lesion (When Two Presentations Collide).

Authors:  Zachary Nicholas; Michael Sughrue; James Battiste; Ozer Algan
Journal:  Cureus       Date:  2016-05-04

8.  Coexistence of Multiple Sclerosis and Brain Tumor: An Uncommon Diagnostic Challenge.

Authors:  Fatemeh Abrishamchi; Fariborz Khorvash
Journal:  Adv Biomed Res       Date:  2017-08-14

9.  Transtentorial herniation from tumefactive multiple sclerosis mimicking primary brain tumor.

Authors:  Kunal Vakharia; Haris Kamal; Gursant S Atwal; James L Budny
Journal:  Surg Neurol Int       Date:  2018-10-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.